Breaking News
Victoria's Secret   Fastenal   Marvell Technology   Zscaler   Gap Inc   Krogger   Costco   Burlington Stores   Macy's  


Fund Families



Latest Q&A Based Profiles ( 8 Interview )


Thomas F. Kirchner

Fund Profile

Event Arbitrage

NA > NA

Pennsylvania Avenue Event-Driven Fund

EQNTX

Dec 12, 2009

Event-driven strategies require a clear understanding of corporate developments and a precise projection of outcome scenarios. As the mutual fund industry is only making the first steps to offering such strategies to investors, Thomas Kirchner at Pennsylvania Avenue Event-Driven Fund focuses on four kinds of opportunities that are linked to
Brady T. Lipp

Fund Profile

Defensive Risk

NA > NA

Akros Absolute Return Fund

Sep 9, 2008

The Akros Absolute Return Fund aims at long-term capital appreciation and income, while seeking to protect principal during unfavorable market conditions. Fund manager Brady T. Lipp uses quantitative factor modeling systems to identify companies of any size selling at a discount to their underlying assets and also companies that can grow
John Geewax

Fund Profile

Looking for Total Return

Mid-Cap > Growth

Quaker Core Value Fund

EAMCX

Nov 11, 2007

Getting the best long-term total return from stocks that appear to be currently underpriced is a difficult task. Quaker Core Value Fund manager John Geewax has quantitative investment approach that involves a blend of value and growth concepts. His team looks at yield, growth, valuation and an acceptable discount rate
Stephan Patten

Fund Profile

Biotech Focus

Science-Technology > NA

Quaker Biotech Pharma-Healthcare Fund

CTYRX

Jul 7, 2006

Scientific breakthroughs in healthcare may spark enthusiasm among investors, but it is estimated that only one out of 5,000 drug candidates actually makes it to the market. That's why investing in biotech requires specialization, in-depth fundamental research, and understanding the complicated drug development process, according to Stephan Patten, co-manager of
Manu Daftary

Fund Profile

Not a Typical Growth Fund

Small-Cap > Value

Quaker Strategic Growth Fund

DEVIX

Oct 10, 2005

Manu Daftary, the manager of Quaker Strategic Growth Fund, has quite a different approach to investing than most growth managers. Instead of chasing the next huge growth winner, he focuses on avoiding the losers. He believes that managers should have as broad a mandate as possible to be able to
J. Michael Barron

Fund Profile

Ahead of the Curve

Large-Cap > Value

Quaker Capital Opportunities Fund

DCGVX

Jun 6, 2005

Know your holdings and you will sleep better. The Quaker Capital Opportunities Fund holds concentrated positions in several diversified sectors. The research approach combines the macro economic analysis with the company research. Over the last five years the fund has stayed ahead of the market by investing in real-estate and
Michael Sjöström

Fund Profile

Investing in Biotech's Best

Science-Technology > NA

Quaker Biotech Pharma-Healthcare Fund

CTYRX

Jul 7, 2003

Although the Quaker Biotech Pharma-Healthcare Fund opened in November, lead manager and sub-adviser Michael Sjöström has more than 10 years experience studying this diverse sector. The approach is both concentrated and flexible, and allows for selling short. Total return for the past six months is more than double the S&P
Manu Daftary

Fund Profile

Winning by Thinking Outside the Box

Science-Technology > NA

Quaker Aggressive Growth Fund

CTHCX

Jun 6, 2003

True, the Quaker Aggressive Growth Fund charter allows its subadviser, Manu Daftary of Boston-based DG Capital, to sell short. However, the veteran manager combines that strategy with a mix of trading, longer term holds, plus the capacity to seek growth opportunities throughout all areas of equity capitalization. Morningstar ranked the
1